The MICs of 88 quinolones against 14 selected reference and clinical strains of Mycobacterium avium-M. intracelulare complex were determined. Agents tested included ciprofloxacin, sparfloxacin (PD During the past decade, much attention has been given to the synthesis of new 4-quinolone-3-carboxylates and the evaluation of these agents for antibacterial activity; this revival of interest was generated by the discovery of the antibacterial activity of nalidixic and oxolinic acids (2-8, 11, 12, 19, 20, 30) . This renewed effort uncovered a number of 6-fluoro-7-piperazino-4-quinolones noteworthy for both the breadth and intensity of their activities against gram-negative bacilli and cocci in vitro and for their capacity to control experimentally induced systemic infections when administered orally (24, 27) . The most active representatives of this class of compounds, designated fluoroquinolones, include norfloxacin, ofloxacin, ciprofloxacin, enoxacin, and pefloxacin (32). The mechanism of action of the quinolone antibacterial agents is believed to result from the combination of their abilities to penetrate into bacterial cells and to inhibit DNA gyrase, an essential bacterial enzyme that maintains superhelical twists in DNA (2, 6, 11, 21, 25) . The general structure of quinolones is shown in Fig. 1 .
evaluation of the most active agents is warranted, as is assessment of structure-activity relationships of active and inactive agents to elucidate the active portions of the compounds and to lead to the development of compounds with enhanced activity.
During the past decade, much attention has been given to the synthesis of new 4-quinolone-3-carboxylates and the evaluation of these agents for antibacterial activity; this revival of interest was generated by the discovery of the antibacterial activity of nalidixic and oxolinic acids (2-8, 11, 12, 19, 20, 30) . This renewed effort uncovered a number of 6-fluoro-7-piperazino-4-quinolones noteworthy for both the breadth and intensity of their activities against gram-negative bacilli and cocci in vitro and for their capacity to control experimentally induced systemic infections when administered orally (24, 27) . The most active representatives of this class of compounds, designated fluoroquinolones, include norfloxacin, ofloxacin, ciprofloxacin, enoxacin, and pefloxacin (32) . The mechanism of action of the quinolone antibacterial agents is believed to result from the combination of their abilities to penetrate into bacterial cells and to inhibit DNA gyrase, an essential bacterial enzyme that maintains superhelical twists in DNA (2, 6, 11, 21, 25) . The general structure of quinolones is shown in Fig. 1 .
Although a large number of quinolone derivatives have been made and their activities have been tested against several groups of bacteria, such as members of the family Enterobacteriaceae and staphylococci, both in vitro and in vivo, the in vitro activity of quinolones against Mycobacterium avium-M. intracellulare complex has only recently been evaluated. M. avium-M. intracellulare complex is of increasing clinical importance as the most frequent bacterial complication of AIDS and also is resistant to most antimicrobial agents (28) .
The fluorinated quinolones show excellent activity in vitro against Mycobacterium tuberculosis, M. kansasii, M. xenopi, and M. fortuitum (9, 10, 14, 15, 26, 31) . Activity against M. avium-M. intracellulare complex, however, is method and strain dependent (9, 10, 14, 15, 17, 22, 26, 30, 31 (3-7, 13, 20, 23 (28) . The medium was prepared by supplementing Bacto Middlebrook 7H9 broth (Difco) with 0.5% glycerol and 100 ml of Bacto Middlebrook OADC enrichment (Difco) per liter. Quinolones were dissolved in 1 N NaOH, diluted in water, incorporated into the medium at concentrations of 0.25 to 32 ,g/ml, and dispensed into 96-well microdilution trays, which were frozen at -70°C until needed. Inocula were prepared from cultures of strains in 4 ml of 7HSF broth which were incubated at 35°C for 1 week. The day before the susceptibility test was done, the 1-week-old culture was diluted 1:20 in fresh 7HSF broth and incubated overnight at 35°C. The overnight culture was mixed by inverting the tube 10 times and then diluted 1:100 MIC90s of >32 ,ug/ml, although MICs for the most susceptible strains were 0.25 to 2 p,g/ml with 25 of the agents and 4 to 16 ,g/ml with 8 of the agents. The remaining 30 agents showed no activity, with all MICs against all strains being >32 ,ug/ml.
As can be seen, besides ciprofloxacin, at least 10 other quinolones show good in vitro activity against the M. avium-M. intracellulare complex strains. Among them, PD 125354 (no. 53 in Fig. 2 ) was found to have the best in vitro activity, on the basis of an MIC50 eightfold lower than that of Fig. 2 ), PD 135144 (no. 56 in Fig. 2 ), sparfloxacin (PD 131501, no. 82 in Fig. 2 ), PD 119421 (no. 71 in Fig. 2 ), PD 131575 (no. 83 in Fig. 2 ), PD 126889 (no. 76 in Fig. 2 ), PD 139586 (no. 59 in Fig. 2 ), PD 143289 (no. 62 in Fig. 2) , and PD 122642 (no. 73 in Fig. 2 (Fig. 3) . MICs for the susceptible and resistant strains were compared for the 54 instances for which MICs of both groups were on scale. MICs for the susceptible strains were 232-fold lower than those for the resistant strains in 11 instances, 4-to 16-fold lower in 36 instances, and .2-fold lower in 7 instances. Overall we find that activity against susceptible strains is a poor predictor of activity against resistant strains. This is shown by the clustering of values along they axis of Fig. 3 . However, good activity against resistant strains guarantees good activity against susceptible strains, as shown by the fact that all the values fall in a triangular area around the y axis of Fig. 3 .
We also compared the activities of the agents against the most susceptible strain overall (TMC 1403) and the most resistant strain (PI 12/39). Twenty agents were highly active against the susceptible strain (MICs, <0.25 ,ug/ml), but only one agent had an MIC of <0.5 p,g/ml and only five had MICs of <2 p,g/ml against the resistant strain. Therefore, activity against resistant strains is a valid indicator of activity against all strains. DISCUSSION While ciprofloxacin is generally regarded as the most active of the quinolones currently in clinical use against M. avium-M. intracellulare complex strains, almost 40% of strains are regarded as resistant to the current clinical breakpoint of 2 ug/ml (28) . Of other quinolones, WIN 57273 has been reported to have activity against M. avium-M.
intracellulare complex, with MIC90s in two studies of 1 and 4 ,g/ml, compared with 1 and 16 ,g/ml for ciprofloxacin (1, 11) ; however, this agent is not being developed further for clinical use. Sparfloxacin (PD 131501, also known as AT-4140) has also been evaluated for activity against M.
avium-M. intracellulare complex, with findings of MICQ0s of 0.5 to 4 p,g/ml, compared with 1 to 16 ,ug/ml for ciprofloxacin (1, 8, 15, 26, 29) . Sparfloxacin has also shown good efficacy in a human macrophage model (22) .
The need for development of quinolones with improved activity against M. avium-M. intracellulare complex is obvious, and several promising candidates have been uncovered in this study, particularly PD 125354, which has an MIC9E of 2 ,ug/ml, fourfold lower than that of ciprofloxacin and twofold lower than that of sparfloxacin.
It is clear from our results that M. avium-M. intracellulare complex strains exhibit variable and progressive resistance to the drugs rather than an abrupt change as would be expected if the drugs were all becoming inactive or if the strains were in two different categories. Fluoroquinolone resistance in bacteria such as staphylococci is due to changes in the DNA gyrase or drug penetration (8, 21) ; the mechanism responsible for the variation seen in M. avium-M. intracellulare complex is unknown. Most of the 88 quinolones tested showed at least some activity against a few strains at the concentrations tested, although activity was typically 4-to 16-fold lower against resistant strains compared with susceptible strains (Fig. 3) . While (6, 16, 18) . Indeed, as the key structural features relevant to activity are identified, they can be used to efficiently optimize the structure of the compounds to achieve optimal activity. 
